Clinical Trial

Detection of Sepsis Occurrence by Using Blood Fluorescence

Recruiting
View on ClinicalTrials.gov →
Summary
This study adopted a case-control study method to explore a reagent-free, highly sensitive, and frequently screened blood fluorescence metabolite analyzer for sepsis, which can detect the emergence of inflammatory free radicals before organ damage and shorten the diagnosis time of sepsis.
Trial Details
NCT Number NCT06689189
Lead Sponsor Ningbo Medical Center Lihuili Hospital
Collaborators: University of Macau
Conditions Sepsis, Organ Damage
Enrollment 800 participants
Start Date 2024-01-24
Primary Completion 2026-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-14